Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a] pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition

被引：11

作者：

Akiu, Mayuko ^{[1
]}

Tsuji, Takashi ^{[1
]}

Sogawa, Yoshitaka ^{[1
]}

Terayama, Koji ^{[1
]}

Yokoyama, Mika ^{[1
]}

Tanaka, Jun ^{[1
]}

Asano, Daigo ^{[1
]}

Sakurai, Ken ^{[1
]}

Sergienko, Eduard ^{[2
]}

Sessions, E. Hampton ^{[2
]}

Gardell, Stephen J. ^{[3
]}

Pinkerton, Anthony B. ^{[2
]}

Nakamura, Tsuyoshi ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan

[2] Sanford Burnham Prebys Med Discovery Inst, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA

[3] AdventHealth, Translat Res Inst, Orlando, FL 32804 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2021年 / 43卷

关键词：

NAMPT activators; NAD plus; Triazolopyridines; CYP inhibition; LogD; NAD BIOSYNTHESIS; MITOCHONDRIAL; METABOLISM; MONONUCLEOTIDE; SIRTUINS; RIBOSIDE; STATE;

D O I：

10.1016/j.bmcl.2021.128048

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate-limiting step of the NAD+ salvage pathway. Since NAD+ plays a pivotal role in many biological processes including metabolism and aging, activation of NAMPT is an attractive therapeutic target for treatment of diverse array of diseases. Herein, we report the continued optimization of novel urea-containing derivatives which were identified as potent NAMPT activators. Early optimization of HTS hits afforded compound 12, with a triazolopyridine core, as a lead compound. CYP direct inhibition (DI) was identified as an issue of concern, and was resolved through modulation of lipophilicity to culminate in 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea (21), which showed potent NAMPT activity accompanied with attenuated CYP DI towards multiple CYP isoforms.

引用

页数：7

共 50 条

[1] 2-[3-(Pyridin-1-ium-2-yl)-1H-pyrazol-1yl]-6-[3-(pyridin-2-yl)-1H-pyrazol-1-yl]pyridinium sulfate methanol monosolvate
Huang, Linxia
Shu, Mouhai
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O689 - +
[2] Oxidative cyclization of 1-(pyridin-2-yl)guanidine derivatives: a synthesis of [1,2,4]triazolo[1,5-a]pyridin-2-amines and an unexpected synthesis of [1,2,4]triazolo[4,3-a]pyridin-3-amines
Ishimoto, Kazuhisa
Nagata, Toshiaki
Murabayashi, Mika
Ikemoto, Tomomi
TETRAHEDRON, 2015, 71 (03) : 407 - 418
[3] 3-Methyl-1-(pyridin-2-yl)-4-(1-pyridin-2-yl-3-methyl-1H-pyrazol-5-yl)-2H-3-pyrazolin-5(1H)-one
Djerrari, B
Essassi, EM
Fifani, J
Pierrot, M
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2001, 57 : O1126 - O1127
[4] 1,4-Bis[1-(pyridin-4-ylmethyl)-1H-benzimidazol-2-yl]butane dihydrate
Li, Shun-Li
Liu, Jie
Ma, Jian-Fang
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O4509 - U3204
[5] 2-[2-(1H-Imidazol-3-ium-5-yl)ethyl]-3-(pyridin-2-yl)-2H-imidazo[1,5-a]pyridin-4-ium bis(perchlorate)
Turkyilmaz, Murat
Baran, Yakup
Ozdemir, Namik
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1282 - U1821
[6] 1-[3-(Anthracen-9-yl)-5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone
Zhang, Shi-Lu
Huang, Kun
Qin, Da-Bin
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1370 - +
[7] 4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type I receptor kinase
Jin, Cheng Hua
Krishnaiah, Maddeboina
Sreenu, Domalapally
Subrahmanyam, Vura Bala
Park, Hyun-Ju
Park, So-Jung
Sheen, Yhun Yhong
Kim, Dae-Kee
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (09) : 2724 - 2732
[8] 2-{[2-(Pyridin-4-yl)-1H-benzimidazol-1-yl] methyl} phenol
Omer, Mohammed A. S.
Liu, Jia-Cheng
Xiao, Chao-Hu
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O700 - +
[9] Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin-2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors
Krishnaiah, Maddeboina
Jin, Cheng Hua
Sreenu, Domalapally
Subrahmanyam, Vura Bala
Rao, Kota Sudhakar
Son, Do-Hyun
Park, Hyun-Ju
Kim, Seung Won
Sheen, Yhun Yhong
Kim, Dae-Kee
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 57 : 74 - 84
[10] Ambient-Temperature Synthesis of (E)-N-(3-(tert-Butyl)-1-methyl-1H-pyrazol-5-yl)-1-(pyridin-2-yl)methanimine
Becerra, Diana
Cobo, Justo
Castillo, Juan-Carlos
MOLBANK, 2021, 2021 (03)

← 1 2 3 4 5 →